Altamira Therapeutics to Host Full Year 2023 Financial Results and Business Update Call on April 10, 2024GlobeNewsWire • 04/04/24
Altamira Therapeutics Announces Collaboration with Univercells Group on Nanoparticle-Delivered mRNA VaccinesGlobeNewsWire • 03/25/24
Altamira Therapeutics' Peptide-Based Delivery Platform Shown to Enhance Potency of Commonly Used Gene Delivery Method as Published in Peer-Reviewed JournalGlobeNewsWire • 02/07/24
Altamira Therapeutics Files Second Provisional Patent Application for OligoPhore Nanoparticles Targeting Different KRAS Mutations in Cancer TreatmentGlobeNewsWire • 01/24/24
Altamira Therapeutics to Present at 3rd Annual mRNA-Based Therapeutics SummitGlobeNewsWire • 01/08/24
Altamira Therapeutics Regains Compliance with Nasdaq Minimum Bid Price RequirementGlobeNewsWire • 12/29/23
Altamira Therapeutics to Host Investor & Business Update Call on December 11thGlobeNewsWire • 12/05/23
These advisers say markets are expecting unrealistic outcomes. Here are some alternatives.Market Watch • 11/30/23
Altamira Therapeutics Regains Compliance with Nasdaq Minimum Stockholders' Equity RequirementGlobeNewsWire • 11/29/23
Altamira Therapeutics Announces European Patent Office Decision to Grant for Patent Application Covering Intranasal BetahistineGlobeNewsWire • 11/10/23
Altamira Therapeutics Reports Additional Significant Efficacy Outcomes from Bentrio Clinical Trial in Seasonal Allergic RhinitisGlobeNewsWire • 09/14/23
Altamira Therapeutics Provides Business Update and First Half 2023 Financial ResultsGlobeNewsWire • 09/12/23
Altamira Therapeutics to Host First Half 2023 Financial Results and Business Update Call on September 12thGlobeNewsWire • 09/06/23
Altamira Therapeutics to Present at H.C. Wainwright 25th Annual Global Investment Conference September 11-13GlobeNewsWire • 08/23/23
Altamira Therapeutics and Pharma Nordic Collaborate for Marketing and Distribution of Bentrio in ScandinaviaGlobeNewsWire • 07/20/23
Altamira Therapeutics Announces Publication of Positive Results from Clinical Trial with Bentrio in House Dust Mite Allergy in Leading Peer Reviewed JournalGlobeNewsWire • 07/17/23